Published: January 03, 2019
Richard Beger, Warwick Dunn, Abbas Bandukwala, Bianca Bethan, David Broadhurst, Clary Clish, Surendra Dasari, Leslie Derr, Annie Evans, Steve Fischer, Thomas Flynn, Thomas Hartung, David Herrington, Richard Higashi, Ping-Ching Hsu, Christina M. Jones, Maureen Kachman, Helen Karuso, Gary Kruppa, Katrice A. Lippa, Padma Maruvada, Jonathan Mosley, Ionna Ntai, Clair O?Donovan, Mary Playdon, Daniel Raftery, Daniel Shaughnessy, Amanda Souza, Timothy Spaeder, Barbara Spalholz, Mukesh Verma, Tilman Walk, Ian Wilson, Daniel Bearden, Krista Zanetti
We describe here the agreed upon first development steps and priority objectives of a community engagement effort to address current challenges in quality assurance (QA) and quality control (QC) in untargeted metabolomic studies. This has included (1) a QA and QC questionnaire responded to by the metabolomics community in 2015 which recommended education of the metabolomics community, development of appropriate standard reference materials and providing incentives for laboratories to apply QA and QC; (2) a 2-day Think Tank on Quality Assurance and Quality Control for Untargeted Metabolomic Studies held at the National Cancer Institutes Shady Grove Campus and (3) establishment of the Metabolomics Quality Assurance and Quality Control Consortium (mQACC) to drive forward developments in a coordinated manner.
Citation: Nature - Scientific Reports
Pub Type: Journals
Created January 03, 2019, Updated March 06, 2019